ATE286906T1 - DIPHOSPHAT-SALZ VON EINEM 4ß-SUBSTITUTIERTE-9- DEOXO-9A-AZA-9A-HOMOERYTHROMYIN-DERIVAT UND SEINE PHARMAZEUTISCHE ZUBEREITUNG - Google Patents

DIPHOSPHAT-SALZ VON EINEM 4ß-SUBSTITUTIERTE-9- DEOXO-9A-AZA-9A-HOMOERYTHROMYIN-DERIVAT UND SEINE PHARMAZEUTISCHE ZUBEREITUNG

Info

Publication number
ATE286906T1
ATE286906T1 AT00931491T AT00931491T ATE286906T1 AT E286906 T1 ATE286906 T1 AT E286906T1 AT 00931491 T AT00931491 T AT 00931491T AT 00931491 T AT00931491 T AT 00931491T AT E286906 T1 ATE286906 T1 AT E286906T1
Authority
AT
Austria
Prior art keywords
homoerythromyine
deoxo
aza
derivative
substituted
Prior art date
Application number
AT00931491T
Other languages
English (en)
Inventor
Robert Rafka
Colman Brendan Ragan
Douglas John Meldrum Allen
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of ATE286906T1 publication Critical patent/ATE286906T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT00931491T 1999-06-30 2000-06-13 DIPHOSPHAT-SALZ VON EINEM 4ß-SUBSTITUTIERTE-9- DEOXO-9A-AZA-9A-HOMOERYTHROMYIN-DERIVAT UND SEINE PHARMAZEUTISCHE ZUBEREITUNG ATE286906T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14168199P 1999-06-30 1999-06-30
PCT/IB2000/000785 WO2001002414A1 (en) 1999-06-30 2000-06-13 Diphosphate salt of a 4''-substituted-9-deoxo-9a-aza-9a-homoerythromycin derivative and its pharmaceutical composition

Publications (1)

Publication Number Publication Date
ATE286906T1 true ATE286906T1 (de) 2005-01-15

Family

ID=22496734

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00931491T ATE286906T1 (de) 1999-06-30 2000-06-13 DIPHOSPHAT-SALZ VON EINEM 4ß-SUBSTITUTIERTE-9- DEOXO-9A-AZA-9A-HOMOERYTHROMYIN-DERIVAT UND SEINE PHARMAZEUTISCHE ZUBEREITUNG

Country Status (42)

Country Link
US (3) US6465437B1 (de)
EP (1) EP1189913B1 (de)
JP (1) JP2003503506A (de)
KR (1) KR100442508B1 (de)
CN (2) CN1358188A (de)
AP (1) AP2001002370A0 (de)
AR (1) AR035551A1 (de)
AT (1) ATE286906T1 (de)
AU (1) AU772277B2 (de)
BG (1) BG65587B1 (de)
BR (1) BR0012091A (de)
CA (1) CA2376748C (de)
CO (1) CO5190679A1 (de)
CZ (1) CZ20014571A3 (de)
DE (1) DE60017399T2 (de)
EA (1) EA004235B1 (de)
EC (1) ECSP003555A (de)
EE (1) EE05068B1 (de)
ES (1) ES2233380T3 (de)
GT (2) GT200000105A (de)
HN (1) HN2000000090A (de)
HR (1) HRP20010919B1 (de)
HU (1) HUP0201693A3 (de)
IL (1) IL146408A0 (de)
IS (1) IS6159A (de)
MA (1) MA26745A1 (de)
MX (1) MXPA02000058A (de)
MY (1) MY133360A (de)
NO (1) NO20016221L (de)
OA (1) OA11965A (de)
PA (1) PA8496901A1 (de)
PE (1) PE20010287A1 (de)
PL (1) PL201891B1 (de)
PT (1) PT1189913E (de)
SK (1) SK286243B6 (de)
TN (1) TNSN00143A1 (de)
TR (1) TR200103834T2 (de)
UA (1) UA71013C2 (de)
UY (1) UY26221A1 (de)
WO (1) WO2001002414A1 (de)
YU (1) YU88701A (de)
ZA (1) ZA200110453B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465437B1 (en) * 1999-06-30 2002-10-15 Pfizer Inc. Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
US6791660B1 (en) * 2002-02-12 2004-09-14 Seiko Epson Corporation Method for manufacturing electrooptical device and apparatus for manufacturing the same, electrooptical device and electronic appliances
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
EP2736915A1 (de) 2011-07-27 2014-06-04 Farma GRS, d.o.o. Neue kristalline formen von tulathromycin
CN106008622A (zh) * 2016-08-02 2016-10-12 海门慧聚药业有限公司 泰拉霉素新晶型及其制备
CN110885351A (zh) * 2019-12-17 2020-03-17 海门慧聚药业有限公司 泰拉霉素磷酸盐的晶型及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
SI9011409A (en) * 1990-07-18 1995-10-31 Pliva Pharm & Chem Works O-methyl azitromycin derivates, methods and intermediates for their preparation and methods for preparation of pharmaceuticals products which comprise them
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
JP2003512290A (ja) * 1997-09-10 2003-04-02 メルク エンド カムパニー インコーポレーテッド 家畜抗菌剤としての８ａ−アザライド
UA70972C2 (uk) * 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків
PT1189912E (pt) * 1999-05-18 2008-05-16 Pfizer Prod Inc Novas formas cristalinas de um antibiótico macrólido
US6465437B1 (en) * 1999-06-30 2002-10-15 Pfizer Inc. Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition

Also Published As

Publication number Publication date
OA11965A (en) 2006-04-12
MXPA02000058A (es) 2002-07-02
MA26745A1 (fr) 2004-12-20
HUP0201693A3 (en) 2003-03-28
TR200103834T2 (tr) 2002-05-21
DE60017399T2 (de) 2006-03-30
ZA200110453B (en) 2003-03-04
YU88701A (sh) 2004-09-03
PE20010287A1 (es) 2001-03-05
BG106123A (en) 2002-05-31
ES2233380T3 (es) 2005-06-16
PL201891B1 (pl) 2009-05-29
UY26221A1 (es) 2001-01-31
KR20020016875A (ko) 2002-03-06
HRP20010919B1 (en) 2005-06-30
EA004235B1 (ru) 2004-02-26
CZ20014571A3 (cs) 2002-04-17
AP2001002370A0 (en) 2001-12-31
PL352900A1 (en) 2003-09-22
IL146408A0 (en) 2002-07-25
GT200000105AA (es) 2001-12-20
JP2003503506A (ja) 2003-01-28
UA71013C2 (uk) 2004-11-15
PA8496901A1 (es) 2002-08-26
CO5190679A1 (es) 2002-08-29
US6861412B2 (en) 2005-03-01
NO20016221D0 (no) 2001-12-19
DE60017399D1 (de) 2005-02-17
CN1358188A (zh) 2002-07-10
CA2376748A1 (en) 2001-01-11
KR100442508B1 (ko) 2004-07-30
HN2000000090A (es) 2001-04-20
BG65587B1 (bg) 2009-01-30
SK18922001A3 (sk) 2002-04-04
HUP0201693A2 (en) 2002-10-28
PT1189913E (pt) 2005-04-29
US7297682B2 (en) 2007-11-20
AU772277B2 (en) 2004-04-22
US6465437B1 (en) 2002-10-15
CA2376748C (en) 2006-03-14
MY133360A (en) 2007-11-30
ECSP003555A (es) 2002-01-25
EE05068B1 (et) 2008-08-15
AU4943900A (en) 2001-01-22
AR035551A1 (es) 2004-06-16
EA200101178A1 (ru) 2002-06-27
NO20016221L (no) 2001-12-19
SK286243B6 (sk) 2008-06-06
IS6159A (is) 2001-11-13
EP1189913A1 (de) 2002-03-27
WO2001002414A1 (en) 2001-01-11
BR0012091A (pt) 2002-04-02
EP1189913B1 (de) 2005-01-12
US20040209826A1 (en) 2004-10-21
TNSN00143A1 (fr) 2005-11-10
GT200000105A (es) 2001-12-20
EE200100699A (et) 2003-02-17
US20030092642A1 (en) 2003-05-15
CN101220067A (zh) 2008-07-16
HRP20010919A2 (en) 2003-02-28

Similar Documents

Publication Publication Date Title
ATE279193T1 (de) Pharmazeutische zubereitung von moxifloxacin
IS5245A (is) Lyfjablanda úr ómeprasól
PT1119557E (pt) Derivados de indeno- nafto- e benzociclohepta-di-hidrotiazole sua preparacao e sua utilizacao como medicamentos anorecticos
NO2013004I1 (no) axitinib, valgfritt i form av et farmasøytisk aksentabelt salt
DE69629988D1 (de) Pharmazeutisches Grundbestandteil und seine Verwendung
PT1006110E (pt) Derivados de acil-piperazinil-pirimidinas sua preparacao e aplicacao como medicamentos
EE03904B1 (et) Graanul, farmatseutiline doseerimisvorm, graanulite valmistamismeetod ja ravimiga kaetud graanulid
DE69801045D1 (de) Pharmazeutische zusammensetzung zur oralen verabreichung von einem n-piperidin-3-pyrazolcarboxamid-derivat, dessen salzen und deren solvaten
ATE447947T1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
ATE246490T1 (de) Pharmazeutische zusammensetzung von topiramate
PT1083171E (pt) Derivados de pirazolina sua preparacao e aplicacao como medicamentos
ATE401908T1 (de) Pharmazeutische zusammensetzungen von erythropoietin
EE200100632A (et) Amlodipiini ja atorvastatiini ühine sool
DE69325408D1 (de) Pharmazeutische Zubereitung in wässriger Suspensionsform
DE59813619D1 (de) Ascorbinsäurederivate enthaltende kosmetische und pharmazeutische Zubereitungen
DE59915033D1 (de) Pharmazeutische Zubereitung
PT1230230E (pt) Derivados de indeno-di-hidrotiazole sua preparacao e sua utilizacao como medicamentos anorexigenico
ATE273697T1 (de) Pharmazeutische levothyroxinzubereitung
PT1202996E (pt) Compostos de titanio a sua preparacao e a sua utilizacao
ATE286906T1 (de) DIPHOSPHAT-SALZ VON EINEM 4ß-SUBSTITUTIERTE-9- DEOXO-9A-AZA-9A-HOMOERYTHROMYIN-DERIVAT UND SEINE PHARMAZEUTISCHE ZUBEREITUNG
EE200300135A (et) Trüptamiini derivaadid ja analoogsed ühendid ningneid sisaldavad farmatseutilised preparaadid
DE50006823D1 (de) Kosmetische und/oder pharmazeutische zubereitungen
DE69907735D1 (de) Melatoninderivate und diese enthaltende pharmazeutische zubereitung
DE69800970D1 (de) Pyridinderivate und sie enthaltende pharmazeutische zubereitungen
PT1206253E (pt) Preparacoes farmaceuticas solidas contendo nanossois de quitosano e metodo de preparacao

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1189913

Country of ref document: EP

REN Ceased due to non-payment of the annual fee